MAP1LC3A and hepatocellular carcinoma: The same research group also proved that a combination of Axl overexpression and LC3 underexpression in HCC patients who underwent LR was associated with the highest risk of recurrence (90% at 5 years) and mortality (83.2% at 5 years) [74].